Low-dose methotrexate for treatment of severe and overlap chronic graft-versus-host disease

被引：0
|
作者：
Levati, G. [1 ]
Greco, R. [1 ]
Sala, E. [1 ]
Guggiari, E. [1 ]
Malato, S. [1 ]
Marktel, S. [1 ]
Carrabba, M. G. [1 ]
Claudiani, S. [1 ]
Marcatti, M. [1 ]
Lunghi, F. [1 ]
Assanelli, A. [1 ]
Bernardi, M. [1 ]
Peccatori, J. [1 ]
Corti, C. [1 ]
Ciceri, F. [1 ]
Lupo-Stanghellini, M. [1 ]
机构：
[1] Ist Sci San Raffaele, I-20132 Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S448 / S449
页数：2
相关论文
共 50 条
  • [31] Treatment of chronic graft-versus-host disease in 2011
    Inamoto, Yoshihiro
    Flowers, Mary E. D.
    CURRENT OPINION IN HEMATOLOGY, 2011, 18 (06) : 414 - 420
  • [32] Treatment of chronic graft-versus-host disease with bortezomib
    Pai, Chien-Chun Steven
    Chen, Mingyi
    Mirsoian, Annie
    Grossenbacher, Steven K.
    Tellez, Joseph
    Ames, Erik
    Sun, Kai
    Jagdeo, Jared
    Blazar, Bruce R.
    Murphy, William J.
    Abedi, Mehrdad
    BLOOD, 2014, 124 (10) : 1677 - 1688
  • [33] Hydroxychloroquine for the treatment of chronic graft-versus-host disease
    Gilman, AL
    Chan, KW
    Mogul, M
    Morris, C
    Goldman, FD
    Boyer, M
    Cirenza, E
    Mazumder, A
    Gehan, E
    Cahill, R
    Frankel, S
    Schultz, K
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (3A) : 327 - 334
  • [34] THALIDOMIDE FOR THE TREATMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE
    VOGELSANG, GB
    FARMER, ER
    HESS, AD
    ALTAMONTE, V
    BESCHORNER, WE
    JABS, DA
    CORIO, RL
    LEVIN, LS
    COLVIN, OM
    WINGARD, JR
    SANTOS, GW
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (16): : 1055 - 1058
  • [35] Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation
    Antin, JH
    Kim, HT
    Cutler, C
    Ho, VT
    Lee, SJ
    Miklos, DB
    Hochberg, EP
    Wu, CJ
    Alyea, EP
    Soiffer, RJ
    BLOOD, 2003, 102 (05) : 1601 - 1605
  • [36] Low-Dose Antithymocyte Globulin for Treatment of Steroid-Pulse-Resistant Acute Graft-versus-Host Disease
    Kazuteru Ohashi
    Yuji Tanaka
    Shin-ichiro Mori
    Yoshiki Okuyama
    Kiyoshi Hiruma
    Hideki Akiyama
    Hisashi Sakamaki
    International Journal of Hematology, 2003, 77 : 99 - 102
  • [37] Low-dose antithymocyte globulin for treatment of steroid-pulse-resistant acute graft-versus-host disease
    Ohashi, K
    Tanaka, Y
    Mori, S
    Okuyama, Y
    Hiruma, K
    Akiyama, H
    Sakamaki, H
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 77 (01) : 99 - 102
  • [38] Low dose alemtuzumab is effective in the treatment of severe steroid-refractory acute graft-versus-host disease
    Repp, R
    Claviez, A
    Gahn, B
    Schub, N
    Beck, C
    Helm, F
    Gramatzki, M
    BONE MARROW TRANSPLANTATION, 2006, 37 : S97 - S97
  • [39] Chronic graft-versus-host disease
    Rorvik, Synne Dragesund
    Abrahamsen, Ingerid Weum
    Myhre, Anders Eivind
    Vo, Camilla Dao
    Odegaard, Eva Meling
    Bruserud, Oystein
    Gedde-Dahl, Tobias
    Tvedt, Tor Henrik Anderson
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2023, 143 (04) : 337 - 341
  • [40] Chronic graft-versus-host disease
    Bolanos-Meade, Javier
    Vogelsang, Georgia B.
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (20) : 1974 - 1986
12345